位置:首页 > 蛋白库 > ALRF2_MOUSE
ALRF2_MOUSE
ID   ALRF2_MOUSE             Reviewed;         218 AA.
AC   Q9JJW6; Q8C869;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=Aly/REF export factor 2;
DE   AltName: Full=Alyref;
DE   AltName: Full=RNA and export factor-binding protein 2;
GN   Name=Alyref2; Synonyms=Ref2, Refbp2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND INTERACTION
RP   WITH NXF1.
RC   TISSUE=Embryo;
RX   PubMed=10786854; DOI=10.1017/s1355838200000078;
RA   Stutz F., Bachi A., Doerks T., Braun I.C., Seraphin B., Wilm M., Bork P.,
RA   Izaurralde E.;
RT   "REF, an evolutionarily conserved family of hnRNP-like proteins, interacts
RT   with TAP/Mex67p and participates in mRNA nuclear export.";
RL   RNA 6:638-650(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=11158589; DOI=10.1073/pnas.98.3.1030;
RA   Rodrigues J.P., Rode M., Gatfield D., Blencowe B.J., Carmo-Fonseca M.,
RA   Izaurralde E.;
RT   "REF proteins mediate the export of spliced and unspliced mRNAs from the
RT   nucleus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1030-1035(2001).
RN   [4]
RP   FUNCTION, INTERACTION WITH NXF1, AND MUTAGENESIS OF ARG-24; ARG-29; ARG-30
RP   AND ARG-32.
RX   PubMed=18364396; DOI=10.1073/pnas.0709167105;
RA   Hautbergue G.M., Hung M.L., Golovanov A.P., Lian L.Y., Wilson S.A.;
RT   "Mutually exclusive interactions drive handover of mRNA from export
RT   adaptors to TAP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5154-5159(2008).
RN   [5]
RP   METHYLATION AT ARG-24; ARG-32; ARG-37; ARG-40; ARG-166; ARG-171; ARG-173;
RP   ARG-181; ARG-186 AND ARG-188.
RX   PubMed=20129943; DOI=10.1093/nar/gkq033;
RA   Hung M.L., Hautbergue G.M., Snijders A.P., Dickman M.J., Wilson S.A.;
RT   "Arginine methylation of REF/ALY promotes efficient handover of mRNA to
RT   TAP/NXF1.";
RL   Nucleic Acids Res. 38:3351-3361(2010).
RN   [6]
RP   STRUCTURE BY NMR OF 1-155, INTERACTION WITH DDX39B AND NXF1/NXT1
RP   HETERODIMER, DOMAIN, AND RNA BINDING.
RX   PubMed=17000901; DOI=10.1261/rna.212106;
RA   Golovanov A.P., Hautbergue G.M., Tintaru A.M., Lian L.Y., Wilson S.A.;
RT   "The solution structure of REF2-I reveals interdomain interactions and
RT   regions involved in binding mRNA export factors and RNA.";
RL   RNA 12:1933-1948(2006).
RN   [7]
RP   STRUCTURE BY NMR OF 53-155 IN COMPLEXES WITH HHV-1 ICP27 PEPTIDE AND WITH
RP   HVS ORF57 PEPTIDE, INTERACTION WITH HHV-1 ICP27 AND HVS ORF57, AND REGION.
RX   PubMed=21253573; DOI=10.1371/journal.ppat.1001244;
RA   Tunnicliffe R.B., Hautbergue G.M., Kalra P., Jackson B.R., Whitehouse A.,
RA   Wilson S.A., Golovanov A.P.;
RT   "Structural basis for the recognition of cellular mRNA export factor REF by
RT   herpes viral proteins HSV-1 ICP27 and HVS ORF57.";
RL   PLoS Pathog. 7:E1001244-E1001244(2011).
RN   [8]
RP   STRUCTURE BY NMR OF 53-155 IN COMPLEX WITH HHV-1 ICP27 PEPTIDE,
RP   RNA-BINDING, REGION, AND INTERACTION WITH HHV-1 ICP27 PEPTIDE.
RX   PubMed=24550725; DOI=10.1371/journal.ppat.1003907;
RA   Tunnicliffe R.B., Hautbergue G.M., Wilson S.A., Kalra P., Golovanov A.P.;
RT   "Competitive and cooperative interactions mediate RNA transfer from
RT   herpesvirus saimiri ORF57 to the mammalian export adaptor ALYREF.";
RL   PLoS Pathog. 10:E1003907-E1003907(2014).
CC   -!- FUNCTION: Export adapter involved in spliced and unspliced mRNA nuclear
CC       export. Binds mRNA which is transferred to the NXF1-NXT1 heterodimer
CC       for export (TAP/NFX1 pathway); enhances NXF1-NXT1 RNA-binding activity.
CC       {ECO:0000269|PubMed:10786854, ECO:0000269|PubMed:11158589,
CC       ECO:0000269|PubMed:18364396}.
CC   -!- SUBUNIT: Interacts (via N-terminus and RRM domain) with DDX39B and th
CC       NXF1-NXT1 heterodimer. Interacts with HHV-1 ICP27 and HVS ORF57
CC       proteins. {ECO:0000269|PubMed:10786854, ECO:0000269|PubMed:17000901,
CC       ECO:0000269|PubMed:18364396, ECO:0000269|PubMed:21253573,
CC       ECO:0000269|PubMed:24550725}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q86V81}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q86V81}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Refbp2-I;
CC         IsoId=Q9JJW6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Refbp2-II;
CC         IsoId=Q9JJW6-2; Sequence=VSP_008598;
CC   -!- DOMAIN: The RRM domain and the N-terminal region (15-58) seem to be
CC       involved in RNA binding. {ECO:0000269|PubMed:17000901}.
CC   -!- PTM: Arginine methylation reduces RNA binding and enhances mRNA
CC       transfer to the NXF1-NXT1 heterodimer for nuclear export.
CC       {ECO:0000269|PubMed:20129943}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ252141; CAB76384.1; -; mRNA.
DR   EMBL; AK048243; BAC33282.1; -; mRNA.
DR   CCDS; CCDS15497.1; -. [Q9JJW6-1]
DR   RefSeq; NP_062357.3; NM_019484.4.
DR   PDB; 2F3J; NMR; -; A=1-155.
DR   PDB; 2KT5; NMR; -; A=53-155.
DR   PDB; 2YKA; NMR; -; A=53-155.
DR   PDBsum; 2F3J; -.
DR   PDBsum; 2KT5; -.
DR   PDBsum; 2YKA; -.
DR   AlphaFoldDB; Q9JJW6; -.
DR   BMRB; Q9JJW6; -.
DR   SMR; Q9JJW6; -.
DR   BioGRID; 207766; 4.
DR   IntAct; Q9JJW6; 1.
DR   STRING; 10090.ENSMUSP00000080242; -.
DR   iPTMnet; Q9JJW6; -.
DR   PhosphoSitePlus; Q9JJW6; -.
DR   jPOST; Q9JJW6; -.
DR   MaxQB; Q9JJW6; -.
DR   PaxDb; Q9JJW6; -.
DR   PeptideAtlas; Q9JJW6; -.
DR   PRIDE; Q9JJW6; -.
DR   ProteomicsDB; 296102; -. [Q9JJW6-1]
DR   ProteomicsDB; 296103; -. [Q9JJW6-2]
DR   TopDownProteomics; Q9JJW6-1; -. [Q9JJW6-1]
DR   DNASU; 56009; -.
DR   GeneID; 56009; -.
DR   KEGG; mmu:56009; -.
DR   CTD; 56009; -.
DR   MGI; MGI:1913144; Alyref2.
DR   eggNOG; KOG0533; Eukaryota.
DR   InParanoid; Q9JJW6; -.
DR   OrthoDB; 1369069at2759; -.
DR   PhylomeDB; Q9JJW6; -.
DR   BioGRID-ORCS; 56009; 6 hits in 73 CRISPR screens.
DR   ChiTaRS; Alyref2; mouse.
DR   EvolutionaryTrace; Q9JJW6; -.
DR   PRO; PR:Q9JJW6; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q9JJW6; protein.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:MGI.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0035145; C:exon-exon junction complex; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0000346; C:transcription export complex; ISO:MGI.
DR   GO; GO:0062153; F:C5-methylcytidine-containing RNA binding; ISO:MGI.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:MGI.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:MGI.
DR   GO; GO:0006406; P:mRNA export from nucleus; ISO:MGI.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0051028; P:mRNA transport; IDA:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; ISO:MGI.
DR   GO; GO:0000018; P:regulation of DNA recombination; ISO:MGI.
DR   GO; GO:0031297; P:replication fork processing; ISO:MGI.
DR   GO; GO:0006405; P:RNA export from nucleus; ISO:MGI.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0046784; P:viral mRNA export from host cell nucleus; ISO:MGI.
DR   DisProt; DP03043; -.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR025715; FoP_C.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF13865; FoP_duplication; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM01218; FoP_duplication; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chaperone; Cytoplasm; Methylation;
KW   mRNA processing; mRNA splicing; mRNA transport; Nucleus;
KW   Reference proteome; RNA-binding; Spliceosome; Transport.
FT   CHAIN           1..218
FT                   /note="Aly/REF export factor 2"
FT                   /id="PRO_0000081976"
FT   DOMAIN          75..152
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          1..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          16..37
FT                   /note="Sufficient for RNA-binding, interaction with NXF1-
FT                   NXT1"
FT   REGION          54..155
FT                   /note="Interaction with HHV-8 ORF57 protein and with ICP27
FT                   from HHV-1"
FT   REGION          151..218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..18
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        155..170
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        187..203
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         24
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         24
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         32
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         32
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         37
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         37
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         40
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         40
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         166
FT                   /note="Asymmetric dimethylarginine; by PRMT1; in vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         171
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         171
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         173
FT                   /note="Asymmetric dimethylarginine; by PRMT1; in vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         181
FT                   /note="Asymmetric dimethylarginine; by PRMT1; in vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         186
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         186
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1; in
FT                   vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   MOD_RES         188
FT                   /note="Asymmetric dimethylarginine; by PRMT1; in vitro"
FT                   /evidence="ECO:0000269|PubMed:20129943"
FT   VAR_SEQ         198
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10786854"
FT                   /id="VSP_008598"
FT   MUTAGEN         24
FT                   /note="R->E: Impairs interaction with NXF1."
FT                   /evidence="ECO:0000269|PubMed:18364396"
FT   MUTAGEN         29
FT                   /note="R->E: Abolishes interaction with NXF1; when
FT                   associated with E-30."
FT                   /evidence="ECO:0000269|PubMed:18364396"
FT   MUTAGEN         30
FT                   /note="R->E: Abolishes interaction with NXF1; when
FT                   associated with E-29."
FT                   /evidence="ECO:0000269|PubMed:18364396"
FT   MUTAGEN         32
FT                   /note="R->E: Impairs interaction with NXF1."
FT                   /evidence="ECO:0000269|PubMed:18364396"
FT   CONFLICT        151
FT                   /note="A -> T (in Ref. 2; BAC33282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="S -> F (in Ref. 2; BAC33282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="M -> R (in Ref. 2; BAC33282)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..6
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   HELIX           9..17
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          23..25
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          28..32
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   TURN            36..38
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   TURN            41..43
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          75..80
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   HELIX           88..97
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          110..113
FT                   /evidence="ECO:0007829|PDB:2KT5"
FT   STRAND          118..123
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   HELIX           125..134
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          141..144
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   STRAND          146..152
FT                   /evidence="ECO:0007829|PDB:2F3J"
FT   HELIX           153..155
FT                   /evidence="ECO:0007829|PDB:2F3J"
SQ   SEQUENCE   218 AA;  23730 MW;  977901CECDCF18FC CRC64;
     MADKMDMSLD DIIKLNRNQR RVNRGGGPRR NRPAIARGGR NRPAPYSRPK PLPDKWQHDL
     FDSGCGGGEG VETGAKLLVS NLDFGVSDAD IQELFAEFGT LKKAAVDYDR SGRSLGTADV
     HFERRADALK AMKQYKGVPL DGRPMDIQLV ASQIDPQRRP AQSGNRGGMT RSRGSGGFGG
     RGSQGRGRGT GRNSKQQQLS AEELDAQLDA YNARMDTS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024